Related Experiment Video
Updated: Apr 21, 2026

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
Published on: December 23, 2016
A case of extravascular hemolysis with Tk-activation
Chisa Yamada1, Robertson D Davenport1
1Transfusion Medicine Division, Department of Pathology, University of Michigan Ann Arbor, Michigan.
A patient with ovarian cancer developed unexplained extravascular hemolysis after antibiotic treatment. Further blood bank investigations are crucial to identify this rare cause of red blood cell destruction.
Area of Science:
- Hematology
- Oncology
- Clinical Chemistry
Background:
- A 50-year-old female with a 4-year history of ovarian cancer presented with abdominal pain.
- The patient developed extravascular hemolysis following the initiation of antibiotic therapy for a suspected infection.
Purpose of the Study:
- To investigate the cause of unexplained extravascular hemolysis in a patient with ovarian cancer.
- To explore potential rare immunological mechanisms contributing to hemolysis.
Main Methods:
- Standard antigen detection tests were performed.
- A lectin panel was utilized to investigate red blood cell surface interactions.
- Collaboration with the blood bank was initiated for further specialized testing.
Main Results:
- All routine red blood cell antigen detection tests yielded negative results.
- Lectin panel testing indicated possible Tk-antigen activation, suggesting an atypical immune mechanism.
- The specific cause of hemolysis remained undetermined pending further investigation.
Conclusions:
- The patient's hemolysis was not explained by common alloimmune or autoimmune mechanisms.
- Tk-activation is a potential, albeit rare, cause of hemolysis that warrants further investigation.
- Comprehensive laboratory and blood bank testing is essential for diagnosing rare hemolytic conditions.
Related Concept Videos
Hypersensitivity Reactions: Cytolytic Reactions
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Bioactivation and Tissue Toxicity
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

